Drug recall · April 17, 2019
PAPAVERINE-PHENTOLAMINE-PGE1 22.5-0.8MG-8.3MCG/ML INJECTABLE recall
Why: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
PAPAVERINE-PHENTOLAMINE-PGE1 22.5-0.8MG-8.3MCG/ML INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .
- Lots / codes
Lot:26112018@68, 13122018@12, distributed between 09-01-2018 to 02-20-2019.
- Quantity
- 2 prescriptions, 5ml injection
- Company
- Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy, Corvallis, OR
- Distribution
- Dispensed in Oregon
- Initiated
- February 21, 2019 · Voluntary: Firm initiated
- Classified
- April 9, 2019
- Reported
- April 17, 2019
- Ended
- July 23, 2020
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Papaverine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.